Asthma Control Among Patients Receiving Inhaled Corticosteroids in Thailand
Asthma Control Among Patients Who Were Receiving Inhaled Corticosteroids in General Practice in Thailand
Sponsor: AstraZeneca
This observational or N/A phase trial investigates Asthma and is currently completed. AstraZeneca leads this study, which shows 7 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
May 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AstraZeneca
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Amnat Charoen, Thailand, Buriram, Thailand, Chachoengsao, Thailand, Chaiyaphum, Thailand, Chanthaburi, Thailand, Chiang Rai, Thailand, Kalasin, Thailand, Khon Kaen, Thailand, Lopburi, Thailand, Mae Hong Son, Thailand and 16 more location s